Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

The U.S. Solicitor General Has Urged the U.S. Supreme Court to Deny a Medtronic Inc. Petition in a Dispute Over its Pain Pump Device, Parker Waichman LLP Notes
  • USA - English


News provided by

Parker Waichman LLP

May 27, 2014, 18:35 ET

Share this article

Share toX

Share this article

Share toX


"We are hopeful that the Solicitor General’s brief will put an end to Medtronic’s attempts,” said Gary Falkowitz, Managing Attorney at Parker Waichman LLP.

Post this

Port Washington, NY (PRWEB) May 27, 2014 -- A key issue in this case involves “failure-to-warn” claims that may be preempted by federal oversight of high-risk medical devices. Following the high court’s October request that it provide an opinion in a dispute filed by Richard Stengel of Arizona, the Solicitor General stepped in. Stengel alleged he was implanted with a Medtronic, Inc. pain pump, which caused him to develop a granuloma (inflammatory mass) around the area where the pain pump was inserted and removed, causing him to become paraplegic. Allegations also include that Medtronic became aware of the granuloma risk after the pain pump’s pre-market approval (PMA) was granted by the FDA; however, the device maker never revised the warning or submitted risk data to the agency. The case, filed in the U.S. Supreme Court on January 10, 2013, is Medtronic Inc. v. Richard Stengel et ux., case number 10-17755.

While the United States Supreme Court rarely seeks assistance, when it does, it does so through the Office of the Solicitor General of the United States. This so-called “Call for the View of the Solicitor General” is rare, only occurring in about one dozen cases annually. In most—approximately 80 percent—of these cases, the Solicitor General advises the Court against granting the position and the Court typically follows this suggestion.

“This is not the first time that Medtronic has attempted to utilize preemption in personal injury cases filed over claims that its medical device were associated with serious harm to patients. We are hopeful that the Solicitor General’s brief will put an end to Medtronic’s attempts,” said Gary Falkowitz, Managing Attorney at Parker Waichman LLP.

The Court was recently faced with this type of a petition in the highly publicized Stengel v. Medtronic, Inc. case, which was received from the U.S. Court of Appeals for the 11th Circuit, and which had held that the Stengels would be able to bring an action seeking damages from Medtronic for the alleged injuries and the subsequent death of Richard Stengel, allegedly due to the Medtronic pain pump. The Stengels alleged that Medtronic neglected to warn the medical community that the pain pump catheter, implanted in the area of Richard Stengel’s spine, might develop a granuloma, which could lead to collapse, permanent paraplegic injury, and death.

Medtronic relied on a portion of the 1976 Medical Device Amendment (MDA) to the Federal Food, Drug, and Cosmetic Act (FDCA), arguing that it was exempt from any lawsuit that challenged its medical device and noting that the Amendment preempted state laws meant to protect medical consumers. The 11th Circuit Court of Appeals disagreed and relied on a 2008 Supreme Court ruling Riegel v. Medtronic, Inc., in which the high court found that there could be no preemption of state protective laws where those laws parallel federal law and neither add, nor take away, from the federal regulatory scheme. In 2013, a Ninth Circuit panel ruled in favor of Stengel, finding that his claims parallel a federal law duty under the MDA, which bars such claims from being preempted. The 1976 Amendments outline the agency's oversight of medical devices, providing the FDA with authority over device labeling and production, and PMA for specific devices.

Although the U.S. agreed that Stengel's failure-to-warn claim is not preempted, its agreement was not related to the lower court’s reasons. "The court of appeals’ conclusion that respondents’ failure-to-warn claim is not expressly preempted is correct, but for a different and more basic reason than the court identified: The federal requirements relevant to respondents’ claim are not device-specific, and therefore, they do not have preemptive effect under Section 360k(a)," the U.S. said in its brief (Brief for Amicus Curiae filed May 2014, number 12-14252 in the Supreme Court of the United States). The response referred to a section of the FDCA that the high court found protects medical device makers if they have complied with federal law.

The U.S. also distinguished Stengel's case from the groundbreaking Riegel v. Medtronic case, in which the Supreme Court, in 2008, ruled that a company may not be sued under state law should a device that underwent the FDA's PMA cause injury. The Solicitor General argued that, in Riegel, PMA approval of the disputed device created preemptive requirements concerning the device’s labeling, production, and design. (Donna S. Riegel, individually and as administrator of the Estate of Charles R. Riegel, v. Medtronic, Inc., No, 06-179 filed in the Supreme Court of United States, Argued December 4, 2007; Decided February 20, 2008 and United States Court of Appeals, Second Circuit: Charles R. Riegel and Donna S. Riegel, v. Medtronic, Inc., Docket No. 04-0412-CV, decided: May 16, 2006)

At the invitation of the Court, the Solicitor General advised against granting review given that Medtronic’s medical device had not been entitled to preemption in the first instance. In fact, the federal requirements that the Stengels claimed were violated by Medtronic were not specific to the catheter device and involved device-specific requirements protected under preemption under the Amendment. Since that wasn’t the ruling in the Circuit Court of Appeals, the case was “not in a suitable posture for correcting that error.” When FDA requirements are stated in general terms, applying to all devices, those requirements cannot have a preemptive effect under the Medical Device Amendment.

The Supreme Court’s Solicitor General opined that, in the Stengel case, “in any tort claim predicated on a failure to report adverse events to FDA,” the claim may be presented “as a claim that the manufacturer should have discharged its state-law warning duties” by working to update its labeling to reflect the device maker’s updated knowledge that something was wrong. In this case, for example, the Justice may rely on the Solicitor General’s finding, which may stop Medtronic’s attempts to have the Supreme Court review the 11th Circuit’s opinion in favor of the Stengels.”

Parker Waichman LLP continues to offer free legal consultations to victims of injuries allegedly caused by Medtronic medical devices, including Medtronic’s pain pump. If you or a loved one suffered a serious complication or injury after receiving a Medtronic pain pump or other device, please contact our office or visit the firm’s Medtronic Pain Pump Injury page at yourlawyer.com. Free case evaluations are also available by calling 1-800-LAW-INFO (1-800-529-4636).

Gary Falkowitz, Parker Waichman LLP, http://yourlawyer.com, +1 (800) 529-4636, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.